Another study of p16INK4A and p53 immunohistochemical staining pattern showed that loss of p16INK4A expression or overexpression of p53 was more frequently seen in PanIN 3 than in IPMN with severe dysplasia [104]. The gene discussed is CDKN2A; the disease is pancreatic intraductal papillary-mucinous neoplasm.